351003-58-2

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-2-fluorobenzenesulfonamide is used as a pharmaceutical intermediate for the synthesis of various drugs and medicinal products. Its unique structure and properties make it an essential component in the development of pharmaceutical compounds, contributing to the advancement of new treatments and therapies.
Used in Pharmaceutical Research and Development:
In the field of pharmaceutical research and development, 3-Chloro-2-fluorobenzenesulfonamide serves as a key building block for the creation of novel drug candidates. Its presence in the molecular structure can influence the pharmacological properties of the resulting compounds, enabling researchers to explore new avenues for drug discovery and optimization.
Used in Drug Synthesis:
3-Chloro-2-fluorobenzenesulfonamide is utilized in the synthesis of a wide range of pharmaceutical compounds, including antibiotics, anti-inflammatory agents, and antiviral medications. Its versatility and reactivity in chemical reactions facilitate the production of diverse drug molecules with potential therapeutic applications.

Upstream product

• 351003-48-0 3-chloro-2-fluorobenzene-1-sulfonyl chloride 
• 2106-04-9 3-chloro-2-fluoroaniline 

Downstream Products

• 1204573-07-8 3-chloro-2-cyclopropylaminobenzenesulfonamide 
• 1192315-87-9 2-(4-butoxy-benzenesulfonylamino)-5-[3-(3-chloro-2-fluoro-benzene-sulfonylaminocarbonyl)-phenoxy]-benzoic acid 
• 1192317-93-3 C₃₄H₃₄ClFN₂O₉S₂ 

Relevant academic research and scientific papers

Positive allosteric modulators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors belonging to 4-cyclopropyl-3,4-dihydro-2 H -1,2,4-pyridothiadiazine dioxides and diversely chloro-substituted 4-cyclopropyl-3,4-dihydro-2 H -1,2,4-benzot

Two 4-ethyl-substituted pyridothiadiazine dioxides belonging to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor positive allosteric modulators were cocrystallized with the GluA2 ligand binding domain in order to decipher the impact of

Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them

Compounds of formula (I): wherein: RCy represents an unsubstituted or substituted cycloalkyl group or cycloalkylalkyl group,R1, R2, R3 and R4, which may be the same or different, each represent a hydrogen or halogen atom or a nitro group; a cyano group; a hydroxy group; an alkoxy group; an alkyl group; an unsubstituted or substituted amino group; a carboxy group; an alkoxycarbonyl group; an aryloxycarbonyl group; an unsubstituted or substituted aminocarbonyl group. Medicinal products containing the same which are useful in treating or preventing conditions treatable by an AMPA receptor modulator.